Payment overview · 2025
General Payments
$51.79
3 reported records · 3 companies
Healthcare provider profile · identity verified
Narinder S. Basra, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · YUBA CITY, CA · NPI 1962563163
Verified facts
What the public records show
CMS Open Payments records show Narinder S. Basra, M.D. received $51.79 in general payments during 2025 across 3 reported records.
Amgen Inc. accounted for 38.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $19.81 | 38.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $17.83 | 34.4% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $14.15 | 27.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $51.79 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $19.81 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $17.83 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $14.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 743 | 193 |
| Levothyroxine Sodium | Levothyroxine Sodium | 603 | 151 |
| Amlodipine Besylate | Amlodipine Besylate | 462 | 127 |
| Pantoprazole Sodium | Pantoprazole Sodium | 448 | 121 |
| Losartan Potassium | Losartan Potassium | 446 | 117 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 376 | 76 |
| Tamsulosin Hcl | Tamsulosin Hcl | 334 | 80 |
| Gabapentin | Gabapentin | 329 | 86 |
| Furosemide | Furosemide | 291 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 262 | 74 |
| Omeprazole | Omeprazole | 240 | 63 |
| Simvastatin | Simvastatin | 226 | 59 |
| Metformin Hcl | Metformin Hcl | 219 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 211 | 60 |
| Sertraline Hcl | Sertraline Hcl | 200 | 43 |
| Lisinopril | Lisinopril | 197 | 45 |
| Allopurinol | Allopurinol | 191 | 48 |
| Glimepiride | Glimepiride | 181 | 52 |
| Eliquis | Apixaban | 175 | 40 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 171 | 54 |
| Lorazepam | Lorazepam | 162 | 27 |
| Potassium Chloride | Potassium Chloride | 153 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 151 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 150 | 38 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 149 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 142 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 140 | 56 |
| Alprazolam | Alprazolam | 140 | 32 |
| Pravastatin Sodium | Pravastatin Sodium | 131 | 32 |
| Bupropion Xl | Bupropion Hcl | 129 | 23 |
| Cephalexin | Cephalexin | 126 | 100 |
| Jardiance | Empagliflozin | 125 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 122 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 117 | 48 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 114 | 26 |
| Tramadol Hcl | Tramadol Hcl | 113 | 28 |
| Hydralazine Hcl | Hydralazine Hcl | 111 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 109 | 26 |
| Azithromycin | Azithromycin | 108 | 89 |
| Metformin Hcl Er | Metformin Hcl | 107 | 28 |
| Temazepam | Temazepam | 105 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 104 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 104 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 104 | 22 |
| Prednisone | Prednisone | 99 | 52 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 98 | 67 |
| Trazodone Hcl | Trazodone Hcl | 84 | 19 |
| Montelukast Sodium | Montelukast Sodium | 80 | 19 |
| Terazosin Hcl | Terazosin Hcl | 78 | 19 |
| Finasteride | Finasteride | 77 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 76 | 17 |
| Atenolol | Atenolol | 75 | 20 |
| Baclofen | Baclofen | 75 | 32 |
| Carvedilol | Carvedilol | 72 | 19 |
| Alendronate Sodium | Alendronate Sodium | 69 | 17 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 69 | 60 |
| Buspirone Hcl | Buspirone Hcl | 68 | 12 |
| Famotidine | Famotidine | 68 | 24 |
| Levofloxacin | Levofloxacin | 64 | 48 |
| Pregabalin | Pregabalin | 63 | 11 |
| Valsartan | Valsartan | 63 | 14 |
| Ibuprofen | Ibuprofen | 62 | 21 |
| Ezetimibe | Ezetimibe | 61 | 18 |
| Cefdinir | Cefdinir | 59 | 48 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 13 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 58 | 11 |
| Meloxicam | Meloxicam | 56 | 19 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 56 | 16 |
| Benazepril Hcl | Benazepril Hcl | 54 | 14 |
| Diazepam | Diazepam | 54 | suppressed |
| Synthroid | Levothyroxine Sodium | 54 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 44 |
| Mupirocin | Mupirocin | 53 | 37 |
| Glipizide | Glipizide | 52 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | 16 |
| Mounjaro | Tirzepatide | 48 | suppressed |
| Ozempic | Semaglutide | 48 | 11 |
| Ofloxacin | Ofloxacin | 46 | 41 |
| Spironolactone | Spironolactone | 46 | 12 |
| Clotrimazole | Clotrimazole | 44 | 30 |
| Januvia | Sitagliptin Phosphate | 44 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 43 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 40 | 40 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 40 | 13 |
| Levetiracetam | Levetiracetam | 39 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 39 | suppressed |
| Irbesartan | Irbesartan | 38 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 38 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 38 | suppressed |
| Trulicity | Dulaglutide | 38 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 38 | suppressed |
| Nifedipine Er | Nifedipine | 37 | 11 |
| Mirtazapine | Mirtazapine | 35 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 34 | suppressed |
| Celecoxib | Celecoxib | 34 | 16 |
| Donepezil Hcl | Donepezil Hcl | 34 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 34 | suppressed |
| Clonazepam | Clonazepam | 33 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | 25 |
| Premarin | Estrogens, Conjugated | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | 15 |
| Xarelto | Rivaroxaban | 31 | suppressed |
| Lactulose | Lactulose | 30 | 11 |
| Primidone | Primidone | 30 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 29 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 29 | suppressed |
| Ranolazine Er | Ranolazine | 29 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 28 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 21 |
| Lidocaine | Lidocaine | 26 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 26 | suppressed |
| Oxycontin | Oxycodone Hcl | 25 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Dutasteride | Dutasteride | 24 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Fluconazole | Fluconazole | 24 | 21 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Nystatin | Nystatin | 24 | 14 |
| Ramipril | Ramipril | 24 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Metronidazole | Metronidazole | 23 | 19 |
| Novolog Flexpen | Insulin Aspart | 23 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 22 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 22 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 21 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Phenobarbital | Phenobarbital | 21 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 21 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 20 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 20 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 19 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 14 |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Telmisartan | Telmisartan | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Humalog | Insulin Lispro | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 14 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 12 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Nadolol | Nadolol | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 13 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Cholestyramine Light | Cholestyramine | 11 | suppressed |
| Fetzima | Levomilnacipran Hcl | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Toprol Xl | Metoprolol Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $51.79 · 3 records | Amgen Inc. | EVENITY, The Cologuard Plus Collection Kit, ZENPEP | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error